United States · FDA National Drug Code directory
GABAPENTIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72865-252_702f8307-681f-440d-9f1d-3d26141a914b
- Product NDC
- 72865-252
- Form
- CAPSULE
- Composition / generic term
- gabapentin
- Labeler
- XLCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210510
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE in 1 BOTTLE (72865-252-05) · 72865-252-05
- 180 CAPSULE in 1 BOTTLE (72865-252-18) · 72865-252-18
- 270 CAPSULE in 1 BOTTLE (72865-252-27) · 72865-252-27
- 90 CAPSULE in 1 BOTTLE (72865-252-90) · 72865-252-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →